| Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta … JHY Wu, C Foote, J Blomster, T Toyama, V Perkovic, J Sundström, B Neal The lancet Diabetes & endocrinology 4 (5), 411-419, 2016 | 539 | 2016 |
| Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta‐analysis T Toyama, BL Neuen, M Jun, T Ohkuma, B Neal, MJ Jardine, ... Diabetes, Obesity and Metabolism 21 (5), 1237-1250, 2019 | 300 | 2019 |
| Trajectories of kidney function in diabetes: a clinicopathological update M Oshima, M Shimizu, M Yamanouchi, T Toyama, A Hara, K Furuichi, ... Nature Reviews Nephrology 17 (11), 740-750, 2021 | 197 | 2021 |
| Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials BL Neuen, M Oshima, R Agarwal, C Arnott, DZ Cherney, R Edwards, ... Circulation 145 (19), 1460-1470, 2022 | 171 | 2022 |
| Prevalence of chronic kidney disease in Asia: a systematic review and analysis T Liyanage, T Toyama, C Hockham, T Ninomiya, V Perkovic, ... BMJ global health 7 (1), e007525, 2022 | 156 | 2022 |
| Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy M Shimizu, K Furuichi, T Toyama, S Kitajima, A Hara, K Kitagawa, Y Iwata, ... Diabetes Care 36 (11), 3655-3662, 2013 | 149 | 2013 |
| Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis JT Ha, BL Neuen, LP Cheng, M Jun, T Toyama, MP Gallagher, MJ Jardine, ... Annals of internal medicine 171 (3), 181-189, 2019 | 148 | 2019 |
| Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes T Wada, M Haneda, K Furuichi, T Babazono, H Yokoyama, K Iseki, ... Clinical and experimental nephrology 18, 613-620, 2014 | 142 | 2014 |
| Gut microbiota–derived D-serine protects against acute kidney injury Y Nakade, Y Iwata, K Furuichi, M Mita, K Hamase, R Konno, T Miyake, ... JCI insight 3 (20), 2018 | 125 | 2018 |
| Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease C Lo, T Toyama, Y Wang, J Lin, Y Hirakawa, M Jun, A Cass, CM Hawley, ... Cochrane database of systematic reviews, 2018 | 109 | 2018 |
| Nonproteinuric versus proteinuric phenotypes in diabetic kidney disease: a propensity score–matched analysis of a nationwide, biopsy-based cohort study M Yamanouchi, K Furuichi, J Hoshino, T Toyama, A Hara, M Shimizu, ... Diabetes care 42 (5), 891-902, 2019 | 105 | 2019 |
| The impacts of albuminuria and low eGFR on the risk of cardiovascular death, all-cause mortality, and renal events in diabetic patients: meta-analysis T Toyama, K Furuichi, T Ninomiya, M Shimizu, A Hara, Y Iwata, S Kaneko, ... PloS one 8 (8), e71810, 2013 | 101 | 2013 |
| Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency M Shimizu, K Furuichi, H Yokoyama, T Toyama, Y Iwata, N Sakai, ... Clinical and experimental nephrology 18, 305-312, 2014 | 83 | 2014 |
| Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis N Sakai, M Nakamura, KE Lipson, T Miyake, Y Kamikawa, A Sagara, ... Scientific reports 7 (1), 5392, 2017 | 80 | 2017 |
| Nationwide multicentre kidney biopsy study of Japanese patients with type 2 diabetes K Furuichi, Y Yuzawa, M Shimizu, A Hara, T Toyama, H Kitamura, ... Nephrology Dialysis Transplantation 33 (1), 138-148, 2018 | 79 | 2018 |
| Post‐progression survival and progression‐free survival in patients with advanced hepatocellular carcinoma treated by sorafenib T Terashima, T Yamashita, N Takata, H Nakagawa, T Toyama, K Arai, ... Hepatology Research 46 (7), 650-656, 2016 | 77 | 2016 |
| Clinical significance of urinary liver-type fatty acid-binding protein as a predictor of ESRD and CVD in patients with CKD K Matsui, A Kamijo-Ikemori, N Imai, T Sugaya, T Yasuda, S Tatsunami, ... Clinical and experimental nephrology 20, 195-203, 2016 | 65 | 2016 |
| The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study M Oshima, M Jun, T Ohkuma, T Toyama, T Wada, ME Cooper, S Hadjadj, ... Diabetologia 62, 1988-1997, 2019 | 60 | 2019 |
| Impairment of the carnitine/organic cation transporter 1–ergothioneine axis is mediated by intestinal transporter dysfunction in chronic kidney disease Y Shinozaki, K Furuichi, T Toyama, S Kitajima, A Hara, Y Iwata, N Sakai, ... Kidney international 92 (6), 1356-1369, 2017 | 60 | 2017 |
| Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients M Oshima, M Jun, KL Chin, CM Hawley, S Zoungas Cochrane Database of Systematic Reviews, 2020 | 59 | 2020 |
Vlado PerkovicDean of Medicine, University of New South Wales; Professorial Fellow, The George Institute在 george.org.au 的电子邮件经过验证
Vlado PerkovicDean of Medicine, University of New South Wales; Professorial Fellow, The George Institute在 george.org.au 的电子邮件经过验证